(Trans)dermal film-forming systems: challenges in design and characterization of an innovative product

  • Ivana Pantelić University of Belgrade – Faculty of Pharmacy, Department of Pharmaceutical Technology and Cosmetology

Abstract


Topical route of drug application offers a range of possibilities, but often with poor patient adherence. Development of formulations that form a discrete film upon application compiles the advantages of (trans)dermal patches and conventional liquid or semisolid topical dosage forms, leading to efficient drug penetration with less frequent use. However, development and characterization of these systems is challenging, and the current draft guideline of the European Medicines Agency (EMA) has opened additional questions. Optimal selection of film-forming polymers (often from the groups of vinyl alcohols, silicones or methacrylates), volatile and non-volatile solvents, plasticizers and/or penetration enhancers, usually requires assistance of an experimental design, along with a holistic QbD concept. Active pharmaceutical ingredient’s (API) solubility must be sufficient in both volatile and non-volatile excipients, leading to its transient supersaturation, without crystallization. Thus, non-volatile excipients generate a matrix film structure that enhances drug delivery into deeper skin layers, without compromising skin barrier integrity. Undoubtedly, when aiming for transdermal delivery, the API itself must meet certain requirements (logP=1-3, MW<500 Da), with the formulation pH set to 7-10. As critical quality attributes (CQAs) of film-forming systems, film drying time, flexibility, integrity and skin substantivity are commonly defined. For volatile solvent-based topical products, EMA’s draft guideline introduced a need to describe transformation/metamorphosis of the drug product on administration. Unfortunately, no specific characterization method is recommended. Hence, the researchers apply a range of techniques: from sophisticated (localized nanothermal analysis, photothermal microspectroscopy), combination of established (rheology, tribology, texture analysis), to development of customized protocols.

References

CHMP/QWP/708282/2018 Draft guideline on quality and equivalence of topical products, European Medicines Agency, 2018.

Kis N, Kovács A, Budai-Szucs M, Gácsi A, Csányi E, Csóka I, Berkó S. Investigation of Silicone-Containing Semisolid in Situ Film-Forming Systems Using QbD Tools. Pharmaceutics 2019; 11 (660): 1-19.

Published
2022/10/18
Section
Invited lectures Session 13